Intellia Therapeutics: A New Paradigm for Hereditary Angioedema as Gene Editing Nears Commercial Reality
In the rapidly evolving landscape of genetic medicine, few companies have captured the attention of Wall Street and the clinical...
In the rapidly evolving landscape of genetic medicine, few companies have captured the attention of Wall Street and the clinical...
In a move set to redefine the economics and efficiency of biopharmaceutical manufacturing, Swedish contract development and manufacturing organization (CDMO)...
NEW YORK CITY — In the heart of midtown Manhattan, the global scientific community converged last week to honor two...
In a move that promises to redefine the trajectory of global biotechnology, China has introduced a transformative regulatory framework: Regulations...
In a move set to redefine the speed of pharmaceutical innovation, IDBS—a premier provider of cloud-based software solutions for the...
The biotechnology sector is experiencing a period of intense activity, marked by a rare combination of massive capital infusion, strategic...
New research from a collaborative team at Arizona State University and Vanderbilt University has fundamentally shifted our understanding of how...
Executive Summary: A New Paradigm in Analytical Precision In a move set to redefine the landscape of biopharmaceutical analytical workflows,...
The manufacturing of Advanced Therapy Medicinal Products (ATMPs)—including gene therapies and cell-based treatments—has long been hampered by the limitations of...
A pioneering study led by researchers at the Children’s Hospital of Philadelphia (CHOP) has unveiled a transformative approach to treating...
In the high-stakes environment of biopharmaceutical manufacturing, the pursuit of perfection is often a zero-sum game. When purifying complex biologics,...
Pancreatic ductal adenocarcinoma (PDAC) stands as one of the most formidable challenges in modern oncology. Characterized by late-stage diagnosis, aggressive...